Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRX-03140 Monotherapy in Alzheimer's Disease
NCT00693004Phase 2Terminated
- Sponsor
- Epix Pharmaceuticals
- Start
- May 2008
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PRX-03140 in Alzheimer's disease (AD), sponsored by Epix Pharmaceuticals. Started May 2008; status: terminated.
02
Drugs
PRX-03140
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00693004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00693004.